×
About 4,205 results

ALLMedicine™ Kawasaki Disease Center

Research & Reviews  1,523 results

An Artificial Intelligence-guided signature reveals the shared host immune response in ...
https://doi.org/10.1038/s41467-022-30357-w 10.1056/NEJMe2023158 10.1001/jama.2020.10369 10.1016/S0140-6736(20)31094-1 10.1136/bmj.m2094 10.1542/peds.54.3.271 10.2188/jea.JE20140089 10.3389/fped.2019.00244 10.1371/journal.pone.0191087 10.1056/NEJMoa2021756 10.1542/peds.2008-1871 10.1016/j.cell.2020.09.034 10.1016/j.cell.2020.09.016 10.1126/sciimmunol.abf7570 10.1016/j.immuni.2021.04.003 10.1038/s41591-020-1054-6 10.1038/s41584-020-00566-y 10.1016/j.ebiom.2021.103390 10.1091/mbc.E19-01-0013 10.1038/nature09907 10.1038/nm1174 10.1203/PDR.0b013e3181baa3c2 10.1253/circj.CJ-66-0096 10.1136/archdischild-2012-302841 10.2188/jea.6.148 10.1161/CIRCULATIONAHA.107.690875 10.1007/s00246-009-9599-7 10.1016/j.jpeds.2020.09.043 10.1038/s41598-018-33124-4 10.4084/mjhid.2020.039 10.1097/INF.0b013e3181dba70b 10.1016/j.jfma.2013.12.008 10.1161/CIRCULATIONAHA.120.048360 10.1016/j.jacc.2020.09.002 10.1016/j.jacc.2020.08.056 10.1136/ard.62.3.264 10.1001/jamapediatrics.2018.2293 10.1038/s41588-018-0102-3 10.1016/j.coph.2004.04.003 10.1038/nrd3800 10.1038/s41591-020-1051-9 10.1016/S0140-6736(20)30858-8 10.1093/labmed/lmaa067 10.1016/j.ijid.2020.08.002 10.1111/jth.14975 10.1007/s00277-020-04019-0 10.1016/j.gendis.2019.09.003 10.3389/fped.2020.614386 10.1371/journal.pone.0244721 10.3389/fped.2020.559389 10.1007/s00246-012-0293-9 10.1111/j.1399-3038.2008.00779.x 10.1016/j.jaci.2020.04.021 10.1111/jcmm.15296 10.1097/FJC.0000000000000061 10.1172/JCI149633 10.2217/fmb.13.104 10.3389/fimmu.2014.00649 10.1186/s12959-018-0170-8 10.1186/2052-0492-1-9 10.1016/j.jcrc.2015.11.010 10.1016/S2352-3026(20)30217-9 10.3389/fcimb.2020.00364 10.1111/all.13811 10.1128/iai.15.2.410-416.1977 10.1172/JCI109789 10.1186/cc6883 10.1016/j.jcrc.2010.03.002 10.1007/s00134-011-2170-z 10.1111/all.14452 10.3346/jkms.2013.28.1.114 10.1161/CIR.0000000000000484 10.1093/nar/gki022 10.1093/nar/gks1193 10.1093/nar/30.1.207 10.1093/nar/gng015 10.1093/biostatistics/4.2.249 10.1186/1471-2105-12-323 10.1093/nar/gkm284 10.1186/gb-2008-9-10-r157 10.1093/nar/gkx1132
Nature Communications; Ghosh P, Katkar GD et. al.

May 17th, 2022 - Multisystem inflammatory syndrome in children (MIS-C) is an illness that emerged amidst the COVID-19 pandemic but shares many clinical features with the pre-pandemic syndrome of Kawasaki disease (KD). Here we compare the two syndromes using a comp...

Neonatal sepsis and Kawasaki disease.
https://doi.org/10.1007/s00431-022-04501-z 10.1016/j.drudis.2016.08.004 10.1038/s41390-021-01780-4 10.3390/antibiotics11020284 10.1111/ped.13809 10.1111/ped.14255 10.1038/s41598-021-92669-z 10.1016/j.scitotenv.2018.11.194 10.1159/000096440 10.1016/j.jinf.2013.04.004 10.1038/ng.2007.59 10.1001/jamanetworkopen.2019.8686 10.1096/fj.201902629R 10.1152/ajpgi.00408.2020 10.1038/s41598-020-69797-z 10.1055/s-0036-1597132
European Journal of Pediatrics; Takeuchi A, Sugino N et. al.

May 16th, 2022 - The purpose of this study is to clarify the relationship between neonatal sepsis and future development of Kawasaki disease (KD). We analyzed data from the National Hospital Organization Neonatal Intensive Care Unit (NHO-NICU) registry study in Ja...

Etanercept with IVIg for acute Kawasaki disease: a long-term follow-up on the EATAK trial.
https://doi.org/10.1017/S1047951122001470
Cardiology in the Young; Sagiv E, Slee A et. al.

May 13th, 2022 - The Etanercept as Adjunctive Treatment for Acute Kawasaki Disease, a phase-3 clinical trial, showed that etanercept reduced the prevalence of IVIg resistance in acute Kawasaki disease. In patients who presented with coronary artery involvement, it...

Clinical Features of Kawasaki Disease With Atlantoaxial Rotatory Fixation.
https://doi.org/10.1097/INF.0000000000003571
The Pediatric Infectious Disease Journal; Michihata N, Suzuki T et. al.

May 12th, 2022 - Atlantoaxial rotatory fixation (AARF) is a rare complication of acute Kawasaki disease (KD). Early diagnosis and intervention are important for AARF because delayed diagnoses may incur neurological sequelae. However, previous studies on AARF assoc...

Intravenous immunoglobulin induces IgG internalization by tolerogenic myeloid dendritic...
https://doi.org/10.1093/cei/uxac046
Clinical and Experimental Immunology; Hsieh LE, Song J et. al.

May 11th, 2022 - Intravenous immunoglobulin (IVIG) is used as an immunomodulatory agent in many inflammatory conditions including Multisystem Inflammatory Syndrome-Children (MIS-C) and Kawasaki disease (KD). However, the exact mechanisms underlying its anti-inflam...

see more →

Guidelines  6 results

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease
https://www.rheumatology.org/Portals/0/Files/Guideline-Management-Kawasaki-Disease.pdf
American College of Rheumatology; Gorelik M, .

Mar 8th, 2022 - Kawasaki disease (KD) is a medium vessel vasculitis as presented in the Chapel Hill Consensus Conference nomenclature system (1). It is 1 of 2 primary common vasculitis syndromes that predominantly affect children (the other being IgA vasculitis...

JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawas...
https://doi.org/10.1253/circj.CJ-19-1094
Circulation Journal : Official Journal of the Japanese Ci... Fukazawa R, Kobayashi J et. al.

Jul 10th, 2020 - JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease.|2020|Fukazawa R,Kobayashi J,Ayusawa M,Hamada H,Miura M,|standards,diagnosis,epidemiology,therapy,standards,diagnosis,epidemiology,therapy,

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statem...
https://doi.org/10.1161/CIR.0000000000000484
Circulation McCrindle BW, Rowley AH et. al.

Mar 31st, 2017 - Kawasaki disease is an acute vasculitis of childhood that leads to coronary artery aneurysms in ≈25% of untreated cases. It has been reported worldwide and is the leading cause of acquired heart disease in children in developed countries. To revis...

Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease ...
https://doi.org/10.1253/circj.cj-66-0096
Circulation Journal : Official Journal of the Japanese Ci...

Sep 23rd, 2014 - Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version.|2014| ,|diagnosis,etiology,genetics,metabolism,therapy,complications,diagnosis,genetics,metabolism,pathology,therapy,

Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease ...
https://doi.org/10.1253/circj.cj-10-74-0903
Circulation Journal : Official Journal of the Japanese Ci...

Aug 21st, 2010 - Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)--digest version.|2010| ,|diagnosis,therapy,complications,epidemiology,

see more →

Drugs  2 results see all →

Clinicaltrials.gov  15 results

A Blood Test to Diagnose Kawasaki Disease
https://clinicaltrials.gov/ct2/show/NCT05091229

Mar 29th, 2022 - Currently, there is no diagnostic tool for Kawasaki disease (KD). Diagnosis is based on clinical features shared with other febrile conditions, frequently resulting in delayed or missed treatment and an increased risk of coronary artery aneurysms....

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease
https://www.rheumatology.org/Portals/0/Files/Guideline-Management-Kawasaki-Disease.pdf
American College of Rheumatology; Gorelik M, .

Mar 8th, 2022 - Kawasaki disease (KD) is a medium vessel vasculitis as presented in the Chapel Hill Consensus Conference nomenclature system (1). It is 1 of 2 primary common vasculitis syndromes that predominantly affect children (the other being IgA vasculitis...

Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease
https://clinicaltrials.gov/ct2/show/NCT04538495

Nov 16th, 2021 - Clinical characterization (Burns, Tremoulet, Sivilay, Roberts, Jain): Over the 8 months of enrollment funded by this supplement, 30 sites will collect data on KD and MIS-C patients using the detailed case report form in our REDCap database. This i...

Defibrotide in Children With High Risk Kawasaki Disease
https://clinicaltrials.gov/ct2/show/NCT04777422

Nov 3rd, 2021 - This study evaluates the safety of defibrotide with IVIG in children with high risk Kawasaki disease.

Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study
https://clinicaltrials.gov/ct2/show/NCT02219165

Jun 8th, 2021 - Staphylococcus aureus and Streptococcus pyogenes produce many virulence factors. Some of them are responsible for severe infections in humans. Superantigen toxins synthesized by S. aureus or by S. pyogenes, are responsible for toxic shock syndrome...

see more →

News  132 results

Kawasaki Disease Guideline Highlights Rheumatology Angles
https://www.medscape.com/viewarticle/970815

Mar 23rd, 2022 - All Kawasaki disease (KD) patients should be treated first with intravenous immunoglobulin, according to an updated guideline issued jointly by the American College of Rheumatology and the Vasculitis Foundation. Dr Mark Gorelik KD has low mortalit...

Kawasaki disease guideline highlights rheumatology angles
https://www.mdedge.com/rheumatology/article/252902/pediatrics/kawasaki-disease-guideline-highlights-rheumatology-angles
Heidi Splete

Mar 18th, 2022 - All Kawasaki disease (KD) patients should be treated first with intravenous immunoglobulin, according to an updated guideline issued jointly by the American College of Rheumatology and the Vasculitis Foundation. KD has low mortality when treated a.

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease
https://www.rheumatology.org/Portals/0/Files/Guideline-Management-Kawasaki-Disease.pdf
American College of Rheumatology; Gorelik M, .

Mar 8th, 2022 - Kawasaki disease (KD) is a medium vessel vasculitis as presented in the Chapel Hill Consensus Conference nomenclature system (1). It is 1 of 2 primary common vasculitis syndromes that predominantly affect children (the other being IgA vasculitis...

Absolute Increase in Long-Term Kawasaki CV Risk Remains Small
https://www.medscape.com/viewarticle/968070

Feb 8th, 2022 - Vasculitis of the coronary arteries is a well-recognized acute complication of Kawasaki disease, but the long-term risk of cardiovascular (CV) sequelae does not appear to be clinically meaningful for most patients, according to results from an ana...

Infliximab Bests Second IVIG Infusion in Refractory Kawasaki Disease
https://www.medscape.com/viewarticle/962520

Nov 9th, 2021 - NEW YORK (Reuters Health) - In children with intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD), infliximab was safe and more effective than a second IVIG infusion in resolving fever, decreasing hospital length of stay, and reducing...

see more →

Patient Education  4 results see all →